The Food and Drug Administration on Friday approved a new Alzheimer’s drug that may modestly slow the pace of cognitive decline early in the disease, but also carries risks of swelling and bleeding in the brain. From a report: The approval of the drug,…

An anonymous reader quotes a report from The Register: Askern Medical Practice, a general practitioner surgery based in Doncaster, UK, managed to muddle its Christmas holiday message to patients by texting them they’d been diagnosed with “aggressive lu…

An anonymous reader quotes a report from Ars Technica: Immune therapies have rewritten the game when it comes to cancer treatment, earning the “fifth pillar” label next to more tried and true treatments like radiation therapy, surgery, and chemotherapy…

Long-time geriatrician James Kirkland is a Mayo clinic researcher joining “a growing movement to halt chronic disease by protecting brains and bodies from the biological fallout of aging,” reports Ars Technica.

“While researchers like Kirkland don’t …